Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis
Publication in refereed journal

替代計量分析
.

其它資訊
摘要Purpose: Emerging studies suggest that low-pass genome sequencing (GS) provides additional diagnostic yield of clinically significant copy-number variants (CNVs) compared with chromosomal microarray analysis (CMA). However, a prospective back-to-back comparison evaluating accuracy, efficacy, and incremental yield of low-pass GS as compared with CMA is warranted.
Methods: A total of 1,023 women undergoing prenatal diagnosis were enrolled. Each sample was subjected to low-pass GS and CMA for CNV analysis in parallel. CNVs were classified according to guidelines of the American College of Medical Genetics and Genomics.
Results: Low-pass GS not only identified all 124 numerical disorders or pathogenic or likely pathogenic (P/LP) CNVs detected by CMA in 121 cases (11.8%, 121/1,023), but also defined 17 additional and clinically relevant P/LP CNVs in 17 cases (1.7%, 17/1,023). In addition, low-pass GS significantly reduced the technical repeat rate from 4.6% (47/1,023) for CMA to 0.5% (5/1,023) and requires less DNA (50-ng) as input.
Conclusions: In the context of prenatal diagnosis, low-pass GS identified additional and clinically significant information with enhanced resolution and increased sensitivity of detecting mosaicism as compared with the CMA platform used. This study provides strong evidence for applying low-pass GS as an alternative prenatal diagnostic test.
出版社接受日期25.07.2019
著者Wang H, Dong Z, Zhang R, Chau M, Yang Z, Tsang K, Wong HK, Gui B, Meng Z, Xiao K, Zhu X, Wang Y, Chen S, Leung TY, Cheung SW, Kwok YK, Morton CC, Zhu Y, Choy KW
期刊名稱Genetics in Medicine
出版年份2020
月份3
卷號22
期次3
頁次500 - 510
國際標準期刊號1098-3600
電子國際標準期刊號1530-0366
語言英式英語
關鍵詞Molecular karyotyping, Low-pass genome sequencing, Copy-number variants, Mosaicism

上次更新時間 2020-06-07 於 02:15